Abstract
Progress in sequencing technology is intrinsically linked to progress in understand cancer genomics. This review aims to discuss the development from Sanger sequencing to next generation sequencing (NGS) technology. We highlight the technical considerations for understanding reports using NGS. We discuss the findings of studies in head and neck cancer using NGS as well as the Cancer Genome Atlas. Finally we discuss future routes for research utilising this methodology and the potential impact of this.
Funding Information
  • Neeraj Sethi is funded by Leeds Charitable Foundation, the Mason Medical Research Foundation, and the Royal College of Physicians and Surgeons of Glasgow.

This publication has 56 references indexed in Scilit: